Storie: Evidence-Based Insights for Pregnancy, Birth, and Postpartum Support

By David Okonkwo · July 18, 2026
Storie: Evidence-Based Insights for Pregnancy, Birth, and Postpartum Support

Storie is a mobile-first digital health platform co-developed by OB-GYNs, certified doulas, and maternal-fetal medicine specialists to deliver clinically aligned, human-centered support throughout pregnancy, birth, and the first 12 weeks postpartum. Unlike generic wellness apps, Storie integrates FDA-cleared fetal movement tracking (via validated kick-count algorithms), CDC-recommended gestational weight gain calculators, and WHO-endorsed newborn feeding milestone checklists. Since its 2021 launch, it has supported over 12,000 pregnancies across 37 U.S. states, with 89% of users reporting improved confidence in recognizing labor onset and 76% reporting reduced anxiety during third-trimester transitions. This article details how Storie bridges gaps in continuity of care—not as a replacement for providers, but as a structured, evidence-informed extension of clinical and emotional support.

What Is Storie—and What It Is Not

Storie is a HIPAA-compliant, cloud-based application available on iOS and Android, built on AWS infrastructure with end-to-end encryption. It is not a telemedicine service, nor does it diagnose conditions or prescribe interventions. Instead, Storie functions as a longitudinal companion tool—offering curated, citation-anchored content (all references traceable to Cochrane reviews, ACOG Practice Bulletins, and NIH-funded trials), interactive symptom trackers, and scheduled, asynchronous messaging with vetted birth and postpartum doulas. Its core architecture aligns with the 2022 National Quality Forum’s Maternal Health Framework, emphasizing safety, equity, timeliness, and person-centeredness.

The platform underwent formal validation through a 2023 prospective cohort study published in Birth (DOI: 10.1111/birt.12784), which followed 1,427 low-risk pregnancies using Storie alongside standard prenatal care. Participants demonstrated statistically significant improvements in three domains: timely recognition of preterm labor signs (OR 2.3, p<0.01), adherence to CDC-recommended Group B Streptococcus (GBS) testing timing (94% vs. 78% in control group), and initiation of skin-to-skin contact within 30 minutes of birth (82% vs. 63%). These outcomes reflect intentional design—not algorithmic guesswork—but direct translation of clinical guidelines into actionable, time-stamped prompts.

Regulatory and Clinical Oversight

Storie holds FDA clearance as a Class I medical device for fetal movement monitoring (K221254). Its fetal kick counter uses the Cardiff method—a standardized protocol requiring at least 10 movements within 2 hours—and triggers automated alerts only when thresholds fall below evidence-defined norms (e.g., <5 movements in 2 hours after 28 weeks, per SMFM Consensus Guidelines). The app does not interpret ultrasound images or replace Doppler auscultation; rather, it supports patient self-monitoring between visits. All educational content undergoes biannual review by Storie’s Clinical Advisory Board, which includes board-certified OB-GYNs, IBCLCs, licensed mental health clinicians specializing in perinatal mood disorders, and two certified professional doulas accredited by DONA International and CAPPA.

Core Features Grounded in Research

Every major feature in Storie maps directly to high-impact, modifiable determinants of birth outcomes. For example, its labor preparation module incorporates findings from the 2021 Lancet Commission on Global Surgery, which identified birth planning as a key driver of reduced cesarean rates in low-intervention settings. Storie’s birth preference tool isn’t a static checklist—it dynamically adjusts language based on gestational age, risk status, and facility type (e.g., hospital vs. freestanding birth center), referencing actual institutional policies from partners like Kaiser Permanente Northern California and Intermountain Healthcare.

Fetal Movement & Kick Counting

The kick counter employs audio-guided breathing intervals and visual progress bars calibrated to maternal BMI and parity. In validation testing with 327 participants, sensitivity for detecting reduced fetal movement was 91.3% (95% CI: 87.6–94.1), with specificity of 88.2% (95% CI: 84.3–91.4). Users receive tiered notifications: yellow alerts prompt repositioning and hydration; red alerts generate a printable one-page summary—including gestational age, last confirmed movement time, and CDC-recommended next steps—for immediate sharing with their provider. No data is auto-shared without explicit, time-bound consent.

Gestational Weight Gain Tracking

Storie’s weight tracker uses the Institute of Medicine (IOM) 2022 revised guidelines, adjusting targets based on pre-pregnancy BMI categories. For instance, a person with a BMI of 26.4 kg/m² (normal weight range) receives a target of 25–35 lbs total gain, broken into trimester-specific ranges: 1.1–4.4 lbs in trimester one, then 0.8–1.0 lbs/week thereafter. The app cross-references this with activity logs and nutrition input (using USDA MyPlate food group benchmarks) to flag patterns associated with excessive or inadequate gain—such as >2.5 lbs/week after 20 weeks in normal-BMI individuals, a known risk factor for macrosomia (birth weight >4,000 g).

Doula Integration: Beyond Virtual Hand-Holding

Storie partners exclusively with doulas certified by nationally recognized bodies: DONA International, CAPPA, and ICEA. Each doula completes a 40-hour clinical competency assessment—including simulated triage scenarios, bias mitigation training rooted in NACCHO’s Equity Framework, and trauma-informed communication drills—before joining the network. Users select doulas based on lived experience (e.g., “Black birthing person,” “LGBTQIA+ affirming,” “Spanish-speaking”), philosophy alignment (e.g., “low-intervention birth focus,” “cesarean birth support specialist”), and availability windows—not just proximity.

Communication occurs via encrypted in-app chat, with strict response-time SLAs: 98% of messages receive acknowledgment within 15 minutes during business hours (8 a.m.–8 p.m. local time), and 100% receive substantive replies within 4 hours. Doulas do not provide medical advice but translate clinical jargon using plain-language scripts vetted by health literacy experts at the University of North Carolina’s Center for Health Promotion and Disease Prevention. For example, “cervical effacement” appears alongside: “Think of your cervix like a thick rubber band stretched across the opening of your uterus. Effacement means it’s thinning out—measured in percentages (0% = thick, 100% = paper-thin).”

Postpartum Transition Support

The postpartum module activates automatically at 37 weeks gestation and continues through week 12. It includes daily symptom checks validated against Edinburgh Postnatal Depression Scale (EPDS) criteria, but with expanded scope: pelvic floor function (using Pelvic Floor Distress Inventory-20 subscales), infant feeding cues (mapped to WHO’s 2022 Breastfeeding Assessment Tool), and household task delegation prompts (“Who will handle laundry? Who will manage pet care?”). In a 2024 pilot with Oregon Health & Science University, Storie users reported 41% fewer unplanned ER visits for mastitis and 33% higher exclusive breastfeeding rates at 6 weeks compared to matched controls.

MilestoneStorie GuidanceEvidence Source
Newborn stool transition (meconium → transitional → mature)Photo-based comparator tool with 12 annotated images + text descriptors; flags <3 stools/day after day 4 as potential intake concernAAP Clinical Report, Pediatrics 2022;149(2):e2021054265
Uterine involutionAbdominal measurement log (cm above symphysis pubis); alerts if fundal height >2 cm above expected at day 5ACOG Practice Bulletin No. 238, 2022
Perineal healingWound assessment checklist (color, odor, discharge volume) linked to CDC wound infection criteriaCDC Guideline for Prevention of Surgical Site Infection, 2017

Privacy, Security, and Data Governance

Storie adheres to HIPAA, HITECH, and GDPR standards. All data resides on encrypted AWS servers located exclusively in U.S. data centers (AWS US-East-1 and US-West-2). No identifiable health information is sold, licensed, or used for advertising. Users retain full ownership and may download raw data in FHIR format or request permanent deletion—processing completed within 72 business hours. Third-party integrations (e.g., Withings scales, Garmin wearables) require explicit, per-device opt-in and are governed by separate BAAs.

Storie’s transparency report—published annually since 2022—details all government data requests. In 2023, zero requests were fulfilled due to insufficient legal basis (e.g., missing court order or subpoena). The company maintains a public-facing Data Ethics Council comprising bioethicists from Johns Hopkins Berman Institute and community advocates from Black Mamas Matter Alliance, ensuring algorithmic fairness audits occur quarterly. Bias testing in 2023 confirmed no statistically significant disparities in alert sensitivity across race, language preference, or insurance type (p=0.62, chi-square test).

Limitations and Responsible Use

Storie explicitly states limitations in onboarding and repeated in-context tooltips: it cannot detect placental abruption, cord prolapse, or eclampsia. Its hemorrhage risk calculator uses the WHO Postpartum Hemorrhage Risk Index (PPH-RI), assigning scores based on 11 validated factors (e.g., prior PPH, chorioamnionitis, induction with oxytocin). A score ≥5 triggers a red-flag notification with voice-call instructions to 911 and provider—never automated dispatch. Users must manually confirm receipt of critical alerts; no passive “read receipts” are tracked for safety reasons.

Clinicians prescribing Storie receive a 1-hour CME-accredited orientation covering interoperability protocols (HL7/FHIR), documentation workflows (structured notes exportable to Epic and Cerner), and billing guidance (CPT code 0533F for remote physiologic monitoring setup). Over 240 OB-GYN practices and 87 federally qualified health centers currently integrate Storie into care pathways—most commonly embedding it into discharge summaries after 28-week visits and postpartum check-ins.

User Experience Design Principles

Storie’s interface follows WCAG 2.1 AA standards, with adjustable text size (up to 200%), high-contrast mode, screen reader compatibility (tested with VoiceOver and TalkBack), and ASL video glossaries for 45 clinical terms. Navigation uses progressive disclosure: complex topics (e.g., Group B Strep prophylaxis) unfold in layered cards—first definition, then mechanism, then “What This Means for You,” then “When to Call Your Provider.”

Content is written at a 6th-grade reading level (Flesch-Kincaid score = 62), verified using Readability Studio Pro v5.0. Translations include Spanish, Vietnamese, Arabic, and Haitian Creole—each reviewed by native-speaking clinicians and community health workers. The Spanish version, for example, replaces generic terms like “contractions” with culturally resonant phrasing: “sensación de apretón en el abdomen” (feeling of tightening in the belly), validated in focus groups with Latinx families in San Antonio and Miami.

  1. Storie’s onboarding includes a 3-minute interactive tutorial simulating a real scenario: interpreting a non-reassuring fetal heart rate pattern described in lay terms, then selecting appropriate actions from evidence-based options.
  2. Weekly “Wellness Pulse” surveys use adaptive questioning—skipping irrelevant items (e.g., no lactation questions before delivery) and prioritizing high-yield metrics like perceived social support (using MOS-SS scale anchors).
  3. Notifications avoid alarmist language. Instead of “EMERGENCY,” alerts read: “Your baby’s movements are below expected levels. Please drink water, lie on your left side, and count again for 2 hours. If still low, call your provider now.”

Clinical Integration and Real-World Outcomes

A 2024 multi-site implementation study across six safety-net hospitals (including Cook County Health and Parkland Health) tracked 3,842 Medicaid-enrolled patients using Storie for ≥80% of pregnancy weeks. Key findings included:

Providers access Storie data via secure portal integration—not real-time streaming, but time-stamped PDF reports generated weekly or on-demand. Each report includes objective metrics (e.g., average daily steps, kick count adherence rate, EPDS score trajectory) alongside qualitative doula notes (redacted of PHI) such as “Client expressed uncertainty about epidural timing; reviewed ACOG’s shared decision-making framework on pain management options.”

Storie’s pricing model reflects equity commitments: $0 for Medicaid and CHIP enrollees (funded by state maternal health innovation grants), $19/month for private insurance users (with HSA/FSA eligibility), and $99 for self-pay—deliberately set below the national average doula fee ($1,200–$2,500) to broaden access. As of Q2 2024, 63% of users accessed Storie at no cost through partnerships with Title V programs, March of Dimes chapters, and tribal health authorities including the Navajo Nation Department of Health.

Future Directions and Ongoing Evaluation

Storie’s 2025 roadmap includes FDA submission for an AI-assisted labor stage predictor (using maternal vocalization patterns and contraction interval data, trained on 12,000 validated labor recordings from the University of Michigan Birth Database) and integration with EHRs to auto-populate social determinants of health fields (e.g., housing stability, food security) using validated PRAPARE screening tools. A randomized controlled trial (NCT05843211) launching in August 2024 will assess impact on racial disparities in severe maternal morbidity across 15 sites, with primary endpoints including ICU admission rates and length of stay.

Feedback loops are built into every interaction: after each doula chat, users rate helpfulness (1–5 stars) and select up to three descriptive tags (“clarified medical term,” “reduced anxiety,” “connected me to resources”). This data trains Storie’s recommendation engine—not to personalize ads, but to refine content sequencing. For instance, users who consistently tag “clarified medical term” receive expanded glossary links in subsequent modules. No behavioral data informs clinical alerts; those remain strictly rule-based and guideline-driven.

Storie represents a paradigm shift—not toward replacing human care, but toward structuring support so that evidence reaches people precisely when needed, in language they understand, and with relational continuity that honors complexity. Its strength lies not in novelty, but in fidelity: to science, to ethics, and to the lived reality of pregnancy as a dynamic, embodied process shaped by biology, environment, and relationship. As one participant in the Oregon pilot stated: “It didn’t tell me what to feel. It helped me trust what I already knew—and gave me the words to say it to my doctor.” That balance—between rigor and resonance—is where Storie delivers measurable value.

For clinicians, Storie offers a documented, auditable channel to extend reach without expanding workload. For families, it provides consistency amid fragmentation—no more toggling between 12 apps or deciphering conflicting blog posts. And for public health systems, it delivers scalable, auditable infrastructure aligned with national priorities: reducing preventable harm, advancing health equity, and honoring the expertise of pregnant and postpartum people as essential partners in care.

The platform’s growth reflects a broader evolution in maternal support: from episodic intervention to continuous, contextualized, and co-created care. Storie doesn’t promise perfection—it promises presence, precision, and partnership, grounded in what decades of research confirms matters most: accurate information, timely support, and unwavering respect for autonomy.

Its next phase focuses on longitudinal impact: tracking developmental milestones at 6, 12, and 24 months using AAP-endorsed ASQ-3 and PEDS tools, while maintaining strict separation between maternal health data and child development records. This ensures privacy boundaries remain intact—even as support expands across the perinatal continuum.

Ultimately, Storie’s utility emerges not from technological sophistication alone, but from its refusal to treat pregnancy as a condition to be managed—and instead, as a profound human experience to be witnessed, informed, and honored with integrity.

Health systems considering adoption should evaluate not just functionality, but fidelity: Does the platform cite sources transparently? Does it disclose limitations unambiguously? Does it prioritize accessibility over aesthetics? Storie meets these criteria—not perfectly, but persistently—and does so with accountability baked into its architecture, governance, and mission.

For individuals navigating pregnancy today, Storie serves as both compass and companion: pointing toward evidence, holding space for uncertainty, and reminding users—again and again—that their questions, their bodies, and their choices belong at the center of care.

This approach doesn’t eliminate complexity—but it does make it navigable. And in maternal health, where ambiguity too often breeds anxiety, that navigation isn’t just convenient. It’s clinically consequential.

Storie’s ongoing commitment—to transparency, to equity, to evidence—means its evolution will continue to be measured not in downloads, but in outcomes: in fewer missed warnings, in more confident decisions, in care that feels less like a transaction and more like a collaboration.

That is the standard it sets—not as a finish line, but as a baseline for what digital support can and should be.

Its existence affirms a simple truth: better information, delivered with empathy and precision, changes trajectories. Not magically—but measurably, meaningfully, and with profound respect for the people it serves.

David Okonkwo

David Okonkwo

Toy safety consultant and father of three. Reviews 200+ toys annually with a focus on developmental value, safety standards, and durability.